NCT06101901Not yet recruiting
Revealing Engagement Dynamics Among Diabetic Kidney Disease Patients
Studying Patterns in Patient Engagement and Participation in Diabetic Kidney Disease Clinical Trials
Source: ClinicalTrials.gov · Last updated 26 Oct 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The study intends to investigate the personal experiences of diabetic kidney disease patients who take part in a separate clinical study including a specific medication intervention. The major focus will be on closely following individuals' rates of trial completion and withdrawal. The data collected from this study will help improve future outcomes for all diabetic kidney disease as well as those in under-represented demographic groups.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 20 Oct 2023
- Start date
- 1 Nov 2024
- Primary completion date
- 30 Nov 2025
- Lead sponsor
- Power Life Sciences Inc.
- Diseases
- Chronic kidney disease
- NCT number
- NCT06101901
What you commit to
- Study type: Observational
- Planned participants: 500
- From 1 Nov 2024 to the primary completion date, 30 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any serious and/or unstable pre-existing medical disorders
Other
- Refusal of consent
- Women of childbearing potential without a negative pregnancy test; or women who are lactating.
Who the study is looking for
- Patients diagnosed with diabetic kidney disease
- Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
- Subjects willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examination.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Power Life Sciences Coordinator of this site? Confirm its status | San Francisco | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.